GlassScriptPhysician profile
Rajiv Pandit
NPI 1356317655
$70,501.65
in general payments reported to CMS, 2019-2025
22 companies · $5,812 in 2025
The $5,812 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $557 · 2021: $31K · 2022: $22K · 2023: $5,226 · 2024: $5,209 · 2025: $5,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $2,020 · Consulting Fee: $1,916 · Travel and Lodging: $733 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,543.75 |
| Food and Beverage | $2,020.18 |
| Consulting Fee | $1,915.90 |
| Travel and Lodging | $733.46 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $38,032.16 | 2021-2022 | |
| Medtronic, INC. | $28,725.64 | 2022-2025 | Propel, Sinuva, Nuvent |
| Stryker Corporation | $1,319.43 | 2019-2025 | Clarifix, Scopis Ent, Clarifix Cryotherapy Device |
| Inspire Medical Systems, INC. | $358.73 | 2023-2024 | Inspire |
| Aerin Medical INC. | $348.50 | 2020-2025 | |
| Kaleo, INC. | $342.92 | 2019-2023 | Auvi-Q |
| Olympus America INC. | $250.00 | 2019-2024 | Rhino-Laryngo Videoscope, Disposable Emr Kit, Diego |
| Sanofi-Aventis U.S. LLC | $228.67 | 2019-2022 | |
| Genzyme Corporation | $214.89 | 2022-2024 | |
| Karl Storz Endoscopy-America | $168.36 | 2019-2025 | |
| Acclarent, INC | $114.47 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $92.42 | 2020-2024 | Dupixent |
| Alk-Abello, INC | $83.73 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $35.27 | 2024-2025 | Ryaltris |
| Amgen INC. | $34.00 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $32.40 | 2025 | Tezspire |
| Carestream Dental, LLC | $30.66 | 2025 | |
| Neurent Medical Limited | $29.13 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Ars Pharmaceuticals Operations, INC. | $28.73 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $12.73 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.94 | 2019 | |
| Ambu INC. | $6.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Pandit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.